Abstract
Daphnetin is mainly extracted from Yu Ruixiang Changbai Daphne. Daphnetin has the pharmacological effects on cardiovascular system, central nervous system, and immune system, which made it mainly used for treatment of coronary heart disease, occlusive vascular disease, and Buerger’s disease in clinical. In the 1970s, the artificial synthesis of daphnetin, which promoted R&D, makes it a landmark of new drug discovery in China. Daphnetin has extensive pharmacological effects, but pharmacological researches are still based on animal experiments. Pharmacodynamics, pharmacokinetics, and clinical research for other indications are needed as soon as possible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jinjun S, Di Liuqing ZX, et al. Determination of equilibrium solubility and apparent oil/water partition coefficient of Daphnetin. J Nanjing Univ Tradit Chin Med. 2011;27(5):449–50.
Plant groups from Traditional Chinese medicine research laboratory, Jilin institute of Chinese medicine. Study of effective component from Changbai daphne – the separation and identification of daphnetin. J Tradit Chin Med. 1977; (4):15–18.
Liu Guoqin, Wang Qiujuan, Yang Sixin et al.. Pharmacological researches on Daphnetin. Chinese Herbal Medicine Study. 1977;8(3):21.
Plant groups from Traditional Chinese medicine research laboratory, Jilin institute of Chinese medicine. Study of Pharmacological effects on Daphnetin. New Med J.1977;(3):142.
Hong L, Weiping L, Xi L, et al. Effect to hemorheology induced by daphnetin and its derivative on type 2 diabetic rats. Jilin Med J. 2010;31(22):3614–6.
Xiulian J, Shuyan Q, Pan G, et al. The inhibition of daphnetin on central nervous system. Chin J ChiniseMeteria Med. 1986;11(3):Cover 2.
Fang H, Tan L. Screening antimalarial activity of daphnetin derivatives and research on their molecular targets. Int J Med Parasit Dis. 2008;35(6):303–4.
Shuyan Q, Yingjie M, Wang Y, et al. Metabolism and pharmacokinetics study of daphnetin. Acta Pharm Sin. 1983;18(7):496–500.
Ying J, Yu F. The influence of different transporters on the oral absorption of daphnetin using Caco – 2 cell model. Pharmacol Clin Chin Mater Med. 2012;28(1):52–6.
Liang SC, Ge GB, Xia YL, et al. In vitro evaluation of the effect of 7-methyl substitution on glucuronidation of daphnetin: metabolic stability, isoform selectivity, and bioactivity analysis. J Pharm Sci. 2015;104(10):2188–209.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Sun, L., Zhao, R., Yang, XY., Du, GH. (2018). Daphnetin. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-8022-7_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8021-0
Online ISBN: 978-981-10-8022-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)